Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of Allogene Therapeutics's Cemacabtagene Ansegedleucel?
Cemacabtagene Ansegedleucel is a gene-modified cell therapy commercialized by Allogene Therapeutics, with a leading Phase II program in Diffuse Large...
Data Insights
Risk adjusted net present value: What is the current valuation of Allogene Therapeutics's Cemacabtagene Ansegedleucel?
Cemacabtagene Ansegedleucel is a gene-modified cell therapy commercialized by Allogene Therapeutics, with a leading Phase II program in Primary Mediastinal...